Thomas P Schaer

faculty photo
Staff Veterinarian, University of Pennsylvania School of Veterinary Medicine
Institute for Medical Translation , University of Pennsylvania School of Veterinary Medicine New Bolton Center
Member, University of Pennsylvania IACUC Board
Member, University of Pennsylvania IACUC Veterinary Advisory Committee

Contact information
University of Pennsylvania
School of Veterinary Medicine
Dept of Clinical Studies
New Bolton Center
382 West Street Road
Kennett Square, PA 19348
Office: 610-925-6237
Fax: 610-925-6820
Education:
VMD (Veterinary Medicine)
University of Pennsylvania School of Veterinary Medicine, 1996.
Permanent link
 

Description of Research Expertise

Thomas catalyzes and supports the translation of science and technology into valuable solutions for his clients, patients and consumers across the medical device, consumer and health tech sectors.
His journey started in human medicine in Switzerland with a deep and everlasting impact by mentor Prof. Maurice E. Mueller (Bern). He has been part of high paced surgical teams treating racehorses, worked with industry to develop and gain approval for medical device products and constantly seeks new opportunities to create value for his organization. He is passionate about being part of the future of healthcare where science intersects with the rapid advancements in healthcare technology.

Our program is focused on pre-clinical and clinical (VICH-GL9) translational research. Leveraging the multi-disciplinary specialties at Penn Vet, our team provides a refined platform for successful translation and de-risking of emerging new technologies using experimental and naturally-occurring disease models. We partner with academia, pharmaceutical and medical-device companies, and government agencies, to meet a broad range of R&D needs.
Specialties: Veterinary Surgery, preclinical study design and execution from proof-of-concept to pivotal trials compliant with the United States Food and Drug Administration (FDA) Good Laboratory Practice (GLP) Regulations, 21 CFR Part 58 and VICH-GL9. Bioskills training and prototype testing.

Description of Itmat Expertise

Dr. Schaer leads preclinical research and testing core at the School of Veterinary Medicine at New Bolton Center. In the current medtech landscape, investors, and ultimately payors (insurance companies, hospitals and patients), require medical innovation that provides value – reducing health care costs through better clinical outcomes and/or reduced procedure costs. This means product development decisions need to be thoughtful of 1) the overall cost for developing a product and 2) the value it brings.
Appropriately aligning your product development efforts, including your preclinical testing, can make your team more efficient increase the likelihood of a successful product. For over a decade I have taken time to listen to you and to understand the product development plan, intended market, and the value proposition for your investigational therapy or device. I have learnt to ask the right questions for choosing a refined preclinical model with high translational fidelity. This approach has delivered answers in the context of the intended clinical indication of your technology. Together we have successfully moved numerous new therapies to market; and we have failed, and failing at the preclinical stage is a whole lot better than later in clinical trials.

Specialties: Preclinical translational research and service core. Preclinical study consulting, design and execution from proof-of-concept to pivotal trials compliant with the United States Food and Drug Administration (FDA) Good Laboratory Practice (GLP) Regulations, 21 CFR Part 58. Bioskills training and protoype testing.
back to top
Last updated: 11/27/2018
The Trustees of the University of Pennsylvania